03 Profile
Vital Signsby Bridgehead
Hansard to 11 November 2026 · 31,429 contributions indexed · 1,439 MPs & peers
All voices01 Voice · Academic · Rare diseases
Jacqueline Shea: no photograph is held, so the academic plate is shown instead.
Academic
Jacqueline Shea
Ph.D., CEO of Inovio
1
Nov 2026to date
1
press citation on 1 topic since 2 Nov 2026 · last quoted 2 Nov 2026
02 Quoted on · 1 of 29 topics
Jacqueline Shea: key facts
- Kind of voice
- Academic
- Role
- Ph.D., CEO of Inovio
- Quoted on
- Rare diseases
- Tracked press citations
- 1
- Most recently quoted
- 2 Nov 2026
04 The signal · where Jacqueline Shea sits on rare diseases
Ranked 49= of 100 voices quoted in the press on rare diseases, level with 51 others on 1 citation.
Ranked on press citations on this topic only, not across all topics. Joint positions share a rank.
- 1Giles LomaxSector leaderChief Executive Officer, Spinal Muscular Atrophy UK (SMA UK)9
- 2Dr Harrison CarterAcademicDirector of Screening at NHS England8
- 3=
Prof Dame Sue HillRegulatorChief Scientific Officer for England and Senior Responsible Officer for Genomics, NHS England7 - 49=Chris WincupClinicianConsultant rheumatologist specialising in lupus at King's College Hospital and senior lecturer at King's College London1
- 49=Isa HouwinkClinicianM.D., Ph.D., Mayo Clinic family medicine physician and senior author of the study1
- 49=Jacqueline SheaAcademicPh.D., CEO of Inovio1
- 49=Michael SumnerSector leaderChief Medical Officer, Inovio1
- 49=Nathaniel MillerClinicianM.D., Mayo Clinic family medicine physician and first author of the study1
Showing the leaders and the ranks around 49=, of 100 voices · See every voice on the topic →
05 On the record · press
What Jacqueline Shea has said
By outlet · linked articles
- fiercepharma.com1
Where Jacqueline Shea has been quoted
- 01Inovio's DNA-based immunotherapy Voceryq approved by FDA for rare HPV airway diseasefiercepharma.com · 2 Nov 2026
Verbatim
“The KOL community is extremely supportive of starting immunotherapy as soon as possible after diagnosis.”
Related media coverage
Recent UK press coverage of their topics, not necessarily citing them directly.
- Coventry tot's heartbreaking health battle after 'extremely rare' diagnosiscoventrytelegraph.net
- Takeda launches sleep disorder pill in the US after DEA clearance removes final hurdlereuters.com
- 'Immoral lottery' - Mum's plea after losing daughter to rare diseasethewestmorlandgazette.co.uk
Professors, researchers and think-tank analysts quoted on the strength of their research rather than a clinical role. Citations are counted by an automated scan of UK press coverage and may be incomplete. Roles, biographies and contact details are researched and human-reviewed before they appear here; anything not yet reviewed is simply absent rather than shown unverified. This profile was last updated on 12 Nov 2026. See the methodology for how this page is built, or email contact@bridgeheadcommunications.com to correct anything on it.